Amicus Therapeutics

Amicus Therapeutics

FOLD

Reported
Wednesday, February 19

Q4 2024 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS0.090.090.000.00%
Revenue148M150M1.84M1.24%
WhatIF - Earnings
EPS Met Expectations
emptyImageAlt
Amicus Therapeutics (FOLD:NASDAQ) has never met expectations before
There’s a first time for everything